Monday, March 30, 2026

Conservative O2 targets (88-92%) safe in PICU, cut respiratory support vs conventional targets

Key Takeaway
Consider conservative oxygen targets (SpO₂ 88-92%) in PICU to reduce duration of respiratory support and oxygen therapy without increasing mortality.

This open-label randomized controlled trial, conducted in a tertiary care pediatric intensive care unit between May 2023 and November 2024, compared conservative versus conventional oxygen saturation targets in critically ill children requiring respiratory support. Children aged 1 month to 15 years requiring invasive or noninvasive oxygen therapy were randomized to conservative (SpO₂ 88-92%) or conventional (SpO₂ 94-99%) targets, with FiO₂ titrated to maintain assigned ranges. The primary outcome was a composite of death and organ support at 30 days. A total of 178 children were randomized, with comparable baseline characteristics and illness severity between groups. The median composite outcome score was 8 (IQR 4-20.25) in the conservative group and 10 (IQR 5-20) in the conventional group, a non-significant difference (p=0.15). Key secondary outcomes showed the conservative group had a significantly shorter duration of respiratory support (4 days vs 6 days; p=0.003) and oxygen therapy (8 hours vs 100 hours; p<0.001). Mortality at 7 and 30 days, organ support days, length of PICU and hospital stay, and oxidative stress assessed by serum malondialdehyde levels at baseline and day 7 were similar between groups. The authors conclude that conservative oxygen saturation targets were safe and resulted in similar mortality and organ dysfunction, with reduced duration of respiratory support and oxygen therapy. They note that larger multicenter trials are needed to confirm these findings.

View Original Abstract ↓
The objective of this study is to compare conservative versus conventional oxygen saturation targets on clinical outcomes in critically ill children requiring respiratory support. This open label randomized controlled trial was conducted in a tertiary care pediatric intensive care unit between May 2023 and November 2024. Children aged 1 month to 15 years requiring invasive or noninvasive oxygen therapy were randomized to conservative (SpO₂ 88-92%) or conventional (SpO₂ 94-99%) oxygen saturation targets. Fraction of inspired oxygen was titrated to maintain assigned targets. The primary outcome was a composite of death and organ support at 30 days. Secondary outcomes included mortality at 7 and 30 days, duration of respiratory support and oxygen therapy, length of PICU and hospital stay, and oxidative stress assessed by serum malondialdehyde (MDA) at baseline and day 7. A total of 178 children were randomized. Baseline characteristics and illness severity were comparable between groups. The median composite outcome score was 8 (IQR 4-20.25) in the conservative group and 10 (IQR 5-20) in the conventional group (p = 0.15). Duration of respiratory support (4 vs 6 days; p = 0.003) and oxygen therapy (8 vs 100 h; p < 0.001) were significantly lower in the conservative group. Mortality at 7 and 30 days, organ support days, length of stay, and MDA levels were similar.Conclusion: Conservative oxygen saturation targets (88-92%) were safe and resulted in similar mortality and organ dysfunction compared with conventional targets, with reduced duration of respiratory support and oxygen therapy. Larger multicenter trials are needed to confirm these findings.Trial registration: The trial is registered in Clinical Trial Registry India (CTRI) (registration number CTRI/2023/11/060105, date of registration 21/11/2023.